Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Peptides ; 21(5): 699-704, 2000 May.
Article in English | MEDLINE | ID: mdl-10876053

ABSTRACT

The interaction between the neuropeptide alpha-MSH and the acetylcholinergic system as reflected by changes in cAMP and inositol 1-3-5 triphosphate(IP(3))production was investigated in an in vitro model of striatal slices. The possible involvement of D(1) receptors in cholinergic and alpha-MSH- stimulated cAMP and IP(3) production in slices of rat striatum was also examined, because it has been demonstrated that acetylcholinergic drugs induce endogenous dopamine release in the striatum. alpha-MSH, pilocarpine(PL) and the selective muscarinic M1 agonist McN-A-343 increased cAMP and IP(3) striatal levels, effects blocked by the D(1) antagonist SCH-23390, except for the effects of alpha-MSH on IP(3). The muscarinic M(2) antagonist gallamine (GL) brought about an increase in cAMP levels, an effect blocked by SCH-23390. The M(1) antagonist pirenzepine (Pz) induced a decrease both in cAMP and IP(3) content, and the nicotinic antagonist di-hydro-beta-eritroidine(DBE) only diminished cAMP production. When alpha-MSH and cholinergic agents were simultaneously added, cAMP and IP(3) levels were modified with respect to the values reached when these agents were added alone. An interaction between the acetylcholinergic system and alpha-MSH through M(1) and nicotinic receptors was also observed. These results suggest that the intracellular signaling pathways related to cAMP and IP(3) production gated by alpha-MSH and these cholinergic receptors are probably related. alpha-MSH striatum cAMP IP(3) muscarinic and nicotinic receptors an in vitro model.


Subject(s)
Acetylcholine/metabolism , Corpus Striatum/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Receptors, Cholinergic/metabolism , alpha-MSH/metabolism , Animals , Inositol 1,4,5-Trisphosphate/biosynthesis , Male , Muscarinic Agonists/pharmacology , Muscarinic Antagonists/pharmacology , Nicotinic Antagonists/pharmacology , Rats , Rats, Wistar , Receptors, Cholinergic/drug effects
2.
Peptides ; 20(5): 611-4, 1999.
Article in English | MEDLINE | ID: mdl-10465513

ABSTRACT

It is known that alpha-MSH augments cAMP levels in rat brain slices containing accumbens and caudate-putamen nuclei. In this study we examined: a) the effect of other neuropeptides: MCH and NEI, on this cyclic nucleotide; b) if the effects of alpha-MSH on cAMP production can be modulated by addition of MCH or NEI to the incubation medium. Both MCH and NEI (3.6 microM) increased the production of cAMP, whereas at doses of 0.6 microM exerted no effects. When alpha-MSH 0.6 microM was added with NEI or MCH (0.6 microM), only MCH blocked the increase in the cAMP induced by alpha-MSH. Neither MCH nor NEI at the highest dose used (3.6 microM) had any additive effect on AMPc when added together with alpha-MSH. We conclude that, at a high concentration, (MCH/NEI)-like peptides can use the intracellular signal transduction linked to cyclic nucleotides in the CNS.


Subject(s)
Corpus Striatum/drug effects , Cyclic AMP/analysis , Hypothalamic Hormones/pharmacology , Melanins/pharmacology , Oligopeptides/pharmacology , Pituitary Hormones/pharmacology , alpha-MSH/pharmacology , Animals , Dose-Response Relationship, Drug , Drug Interactions , Male , Nucleus Accumbens/drug effects , Putamen/drug effects , Rats , Rats, Wistar
3.
Peptides ; 19(2): 383-8, 1998.
Article in English | MEDLINE | ID: mdl-9493872

ABSTRACT

We have tried to investigate the possible interaction between the gabaergic system and alpha-MSH at a cellular level in an in vitro model of male albino rats tissue slices containing accumbens and caudate-putamen nuclei. Alpha-MSH alone increases cAMP levels, as does diazepam and phaclofen; however, these effects were blocked by SCH-23390. Both flumazenil and baclofen induced a decrease in the cAMP content. When both alpha-MSH and gabaergic agents were incubated together, cAMP levels were modified. It can be assumed that cAMP production by the neuropeptide and the gabaergic agents could be linked to the activation of dopaminergic D1 receptors. The latter receptors had no prominent effect on the interaction between alpha-MSH and the GABA agonists and antagonists. In summary, our results suggested that alpha-MSH and GABA system could be biochemically linked to produce a cellular effect.


Subject(s)
Corpus Striatum/drug effects , Corpus Striatum/metabolism , Cyclic AMP/metabolism , GABA Agents/administration & dosage , alpha-MSH/administration & dosage , Animals , Baclofen/administration & dosage , Baclofen/analogs & derivatives , Benzazepines/administration & dosage , Diazepam/administration & dosage , Drug Interactions , Flumazenil/administration & dosage , GABA-A Receptor Agonists , GABA-A Receptor Antagonists , GABA-B Receptor Agonists , GABA-B Receptor Antagonists , In Vitro Techniques , Male , Models, Neurological , Rats , Rats, Wistar , Receptors, Dopamine D1/drug effects , Receptors, Dopamine D1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...